Rite Aid has been banned from using facial recognition technology for five years over allegations that a surveillance system it used incorrectly identified potential shoplifters, especially Black, Latino, Asian or female shoppers
Online, direct-to-consumer health care has grown well beyond its roots mostly treating hair loss and acne or selling birth control pills
Walgreens is chopping its dividend nearly in half as the drugstore chain looks to strengthen its balance sheet
Eli Lilly has launched a unique website to connect U.S. patients seeking obesity treatment to doctors, dieticians and its new weight-loss drug, Zepbound
Prescriptions for ADHD treatments surged among adults during the COVID-19 pandemic, helping to fuel lingering shortages that are frustrating parents and doctors
UnitedHealth Group turned in a better-than-expected fourth quarter but surprised Wall Street with medical costs that soared 16%
Shares of Humana are tumbling after the health insurer said it was still dealing with higher-than-expected care costs from its Medicare Advantage customers and it chopped earnings expectations
Humana surprised Wall Street again on Thursday with a lower-than-expected earnings forecast, as insurers that sell Medicare Advantage plans continue to struggle with rising care costs
Pfizer turned in a better-than-expected fourth quarter, boosted by products outside the drugmaker’s slumping COVID-19 vaccine and treatment
Biogen will stop developing its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster before stumbling soon after its launch a couple of years ago
Telemedicine’s early days of handling mostly mild illnesses like sinus infections or cases of pink eye are fading fast
Eli Lilly rode soaring demand for diabetes and weight-loss treatments to a better-than-expected finish in 2023, and the drugmaker expects momentum to carry into the new year
CVS Health’s fourth-quarter profit fell as the drugstore chain and pharmacy benefits manager dealt with increased operating costs
Drugstore chains CVS Health and Walgreens plan to start dispensing the abortion pill mifepristone in a few states
Federal regulators are putting off a decision on Eli Lilly’s potential Alzheimer’s treatment with an unusual request to have an advisory committee examine the drug
Doctors around the country say insurers are making it harder to get coverage for home ventilators that patients with serious illnesses need as their lungs fail
The first drug shown to slow Alzheimer’s hit the U.S. market over a year ago, but sales have lagged and diagnosis and treatment remain complicated
UnitedHealth Group trounced first-quarter expectations even as costs from a cyberattack to its Change Healthcare business ate into its performance
UnitedHealth says files with personal information that could cover a “substantial portion of people in America” may have been taken in the cyberattack on its Change Healthcare business
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first quarter profit
CVS Health missed first-quarter expectations and chopped its 2024 outlook more than a dollar below Wall Street’s forecast
The beginning of the Change Healthcare cyberattack happened when hackers entered a server that lacked multifactor authentication
The health insurer Aetna has agreed to settle a lawsuit over whether its fertility treatment coverage discriminates against LGBTQ+ patients
The go-broke dates for benefit programs Medicare and Social Security have been pushed back as an improving economy has contributed to changed projected depletion dates, according to the annual Social Security and Medicare trustees report
A cyberattack on the Ascension health system operating in 19 states across the U.S. forced some of its 140 hospitals to divert ambulances, caused patients to postpone medical tests and blocked online access to patient records
Trump has begun another trade war. Here's a timeline of how we got here
Canada's leader laments lost friendship with US in town that sheltered stranded Americans after 9/11
Chinese EV giant BYD's fourth-quarter profit leaps 73%
You're an American in another land? Prepare to talk about the why and how of Trump 2.0
Chalk talk: Star power, top teams and No. 5 seeds headline the women's March Madness Sweet 16
Purdue returns to Sweet 16 with 76-62 win over McNeese in March Madness
